Beranda › Poliradikuloneuropati Demielinasi Inflamasi Kronis › North Carolina
Uji klinis Poliradikuloneuropati Demielinasi Inflamasi Kronis di North Carolina
6 studi untuk Poliradikuloneuropati Demielinasi Inflamasi Kronis mencari peserta di lokasi di North Carolina.
Teks studi resmi (Bahasa Inggris)
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Site Number - 1635, Chapel Hill
- Site Number - 1610, Charlotte
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07032662Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- The Neurological Institute, PA, Charlotte
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT05327114A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Raleigh Neurology Associates- Site Number : 8400043, Raleigh
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06290141Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study
- PPD Virtual, Wilmington
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Apr 2026 · NCT07264426A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- University of North Carolina (UNC), Chapel Hill
- Duke University Hospital, Durham
- Raleigh Neurology Associates, Raleigh
- dan 1 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Jan 2026 · NCT06747351A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care
- Wake Forest University - School of Medicine - Central, Winston-Salem
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Nov 2025 · NCT06538064Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.